Wholeness and implicate order: “Deep” quantum chemistry and cell consciousness: quantum chemistry controls genes and biochemistry to give cells and higher organism’s consciousness and complex behavior

Bohm used the term ‘holomovement’ which is an unbroken and undivided totality and carries an implicate order which is he totality of an order including both the manifested and non-manifested aspects of the order. Non-local quantum phenomena reside in a subtler level than quantum level that is th

[ read more ]

About metabolism of a carcinoma cell

Most cancer cells utilize aerobic glycolysis irrespective of their tissue of origin. The alteration from oxidative phosphorylation to glycolysis – called the Warburg effect – is an universal phenomen and has now become a diagnostic tool for cancer detection. Warburg O, Posener K, Negelein E.

[ read more ]

Variation in cancer risk among tissues can be explained by the number of stem cell divisions

Tomasetti and Vogelstein show that the lifetime risk of cancers of many different types is strongly correlated with the total number of divisions of the normal self-renewing cells maintaining that tissue’s homeostasis. These results suggest that only a third of the variation in cancer risk among t

[ read more ]

Quantum Tunnelling to the Origin and Evolution of Life

Quantum tunnelling is a phenomenon which becomes relevant at the nanoscale and below. It is a paradox from the classical point of view as it enables elementary particles and atoms to permeate an energetic barrier without the need for sufficient energy to overcome it. Tunnelling is being of vital imp

[ read more ]

A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine

Progressive increase in mtDNA 3243A>G heteroplasmy causes abrupt transcriptional reprogramming Wallace hypothesized mitochondrial dysfunction as a central role in a wide range of age-related disorders and various forms of cancer. Steadily rising increases in mitochondrial DNA mutations cause abr

[ read more ]

Quantum entanglement between the electron clouds of nucleic acids in DNA

Rieper, Anders and Vedral modelled the electron clouds of nucleic acids in a single strand of DNA as a chain of coupled quantum harmonic oscillators with dipole-dipole interaction between nearest neighbours. As a main result, the entanglement contained in the chain coincides with the binding energy

[ read more ]

A new theory of the origin of cancer: quantum coherent entanglement, centrioles, mitosis, and differentiation

Low non-specific, low intensity laser illumination (635, 670 or 830 nm) apparently enhances centriole replication and promotes cell division, what is the opposite of a desired cancer therapy. In the contrary, centrioles are sensitive to coherent light. Then higher intensity laser illumination - stil

[ read more ]

Quantum Teleportation and Von Neumann Entropy

From the aspect of the quantum information theories, various quantum entropies are possibly computed at each stage, which ensures the emergence of the entangled states in the intermediate step. If a single qubit quantum teleportation is near the computational basis, the quantum measurement is domina

[ read more ]

Implications of quantum metabolism and natural selection for the origin of cancer cells and tumor progression

Energy transfer in material solids is driven primarily by differences in intensive thermodynamic quantities such as pressure and temperature. The crucial observation  in quantum-theoretical models was the consideration of the heat capacity as associated with the vibrations of atoms in a crystalline

[ read more ]

Mitochondria and the evolutionary roots of cancer

Cancer is a group of almost 200 diseases that involve variety of changes in cell structure, morphology, and physiology. Cancer phenotype is underlying several alterations in cellular dynamics with three most critical features, which includes self-sufficiency in growth signals and insensitivity to in

[ read more ]

New drug blocks pancreatic cancer growth in mice, study finds

A newly developed drug can prevent the most common type of pancreatic cancer from growing and spreading in laboratory mice, according to a new study. The study also demonstrated in mice that the drug, Metavert, may prevent patients from developing a resistance to currently used pancreatic cancer chemotherapies. (Mehr in: Cancer News — ScienceDaily)

Eight of 10 people with cancer risk genes don’t know it

Genomic screening shows that more than 80 percent of those who carry an identifiable genetic risk for breast, ovarian, prostate, and pancreatic cancer don’t know it. (Mehr in: Cancer News — ScienceDaily)

New blood test detects early stage pancreatic cancer

Pancreatic cancer is currently very difficult to detect while it is still resectable. A new blood test can detect pancreatic cancer in the very earliest stages of the disease. (Mehr in: Cancer News — ScienceDaily)

Blocking digestive hormone may prevent diet-induced pancreatic cancer

A high-fat diet may promote the growth of pancreatic cancer independent of obesity because of the interaction between dietary fat and cholecystokinin (CCK), a digestive hormone. In addition, blocking CCK may help prevent the spread of pancreatic tumors to other areas of the body (metastases). (Mehr in: Cancer News — ScienceDaily)

Pancreatic cancer: Mutable cancer cells are more dangerous

Pancreatic cancer often spreads, forming metastases in the liver or lungs. The prognosis is better for patients with metastases in the lungs. However, the organ that is more likely to be affected depends on the cancer cells’ ability to alter their characteristics and shape – as a research team at the Technical University of Munich (TUM) has discovered. (Mehr in: Pressemitteilungen – idw – Informationsdienst Wissenschaft)

How pancreatic tumors lead to weight loss

A study offers insight into the weight loss seen in pancreatic cancer patients, and suggests that weight loss may not necessarily affect patients‘ survival. (Mehr in: Cancer News — ScienceDaily)

New drugs could also be deployed against lung and pancreatic cancers

A new anti-cancer drug may be effective against a wider range of cancers than previously thought. Using a mouse model and samples taken from cancer patients, a team from the Technical University of Munich (TUM) has shown that a new class of drugs known as SHP2 inhibitors is also effective against aggressive, hard-to-treat tumors such as lung and pancreatic cancers. Clinical trials currently underway had previously excluded patients with these cancers. (Mehr in: Pressemitteilungen – idw – Informationsdienst Wissenschaft)

A way to prevent pancreatic cancer from spreading post-surgery?

New research suggests a strategy for lowering the odds of metastasis following successful pancreatic cancer surgery: The post-operative period, suggests a researcher, ‚offers a window during which efforts might be made to keep cortisol levels down and T cells strong so the patient’s own immune system can kill the cancer cells that have made their way to other parts of the body but until this point have been dormant.‘ (Mehr in: Cancer News — ScienceDaily)

Novel theranostic approach for treating pancreatic cancer patients shows promise

German researchers have developed a novel diagnostic and therapeutic (theranostic) procedure for patients with ductal pancreatic adenocarcinoma, a deadly cancer with an extremely poor prognosis (five-year survival rate of less than 5 percent) and limited treatment options. (Mehr in: Cancer News — ScienceDaily)

Injecting gene cocktail into mouse pancreas leads to human-like tumors

A researcher has invented a unique method to generate, in mice, pancreatic tumors that resemble human pancreatic cancer. This will be a tool researchers can use to develop new drugs that extend patients‘ lives, and it is a tool researchers have not had at their disposal before. (Mehr in: Cancer News — ScienceDaily)

Cancer news

Vast leukemia dataset could help researchers match therapies to patients

17. Okt. 2018

Data on the molecular makeup and drug sensitivity of hundreds of patient samples could accelerate progress against the aggressive blood cancer acute myeloid leukemia. (Mehr in: Cancer News — ScienceDaily)

- Read more

Breastfeeding protects infants from antibiotic-resistant bacteria

17. Okt. 2018

A new study shows that infants that are breastfed for at least six months have less antibiotic-resistant bacteria in their gut compared with babies breastfed for a shorter time. On the other hand, antibiotic use by mothers increases the number of antibiotic-resistant bacteria in infants. (Mehr in: Cancer News — ScienceDaily)

- Read more

Lymphatic system, key player in human health

16. Okt. 2018

Defects in the lymphatic system have been linked to a wide range of health consequences, but new findings of how the system works could lead to future therapies. (Mehr in: Cancer News — ScienceDaily)

- Read more

Age-related increase in estrogen may cause common men’s hernia

16. Okt. 2018

An age-related increase in estrogen may be the culprit behind inguinal hernias, a condition common among elderly men that often requires corrective surgery. Men could be treated with hormone inhibitor to strengthen muscle, the researcher suggests. (Mehr in: Cancer News — ScienceDaily)

- Read more

This RNA-based technique could make gene therapy more effective

16. Okt. 2018

Biological engineers have devised a way to regulate the expression of messenger RNA once it gets into cells, giving them more precise control over gene therapy treatments for cancer and other diseases. (Mehr in: Cancer News — ScienceDaily)

- Read more

A bad influence: Interplay between tumor cells and immune cells

16. Okt. 2018

Research has yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ultimately affect response to treatment. (Mehr in: Cancer News — ScienceDaily)

- Read more

Automated system identifies dense tissue, a risk factor for breast cancer, in mammograms

16. Okt. 2018

Researchers have developed an automated model that assesses dense breast tissue in mammograms — which is an independent risk factor for breast cancer — as reliably as expert radiologists. This marks the first time a deep-learning model of its kind has successfully been used in a clinic on real patients, according to the researchers. With broad implementation, the researchers hope the model can help bring greater reliability to breast density assessments across the nation. (Mehr in: Cancer News — ScienceDaily)

- Read more

Diets rich in fish oil could slow the spread and growth of breast cancer cells

16. Okt. 2018

Omega-3 fatty acids, such as those typically contained in fish oil, may suppress the growth and spread of breast cancer cells in mice. (Mehr in: Cancer News — ScienceDaily)

- Read more

New way to determine whether metastatic cancer cells in breast cancer patients are dormant or soon to turn deadly

16. Okt. 2018

For the first time ever, researchers have identified a protein as a marker that can indicate whether a cancer patient will develop a recurrence of lethal, metastatic cancer. (Mehr in: Cancer News — ScienceDaily)

- Read more

Finding better drug ‚fits,‘ avoiding medication tragedies like thalidomide

15. Okt. 2018

Researchers, including chemistry professor and Nobel Prize winner Ei-ichi Negishi, have developed technology to create a new chemical process to synthesize drug-like molecules with ultra-high purity. (Mehr in: Cancer News — ScienceDaily)

- Read more

3D mammography detected 34 percent more breast cancers in screening

15. Okt. 2018

After screening 15,000 women over a period of five years, a major clinical study in Sweden has shown that 3D mammography, or breast tomosynthesis, detects over 30% more cancers compared to traditional mammography — with a majority of the detected tumors proving to be invasive cancers. (Mehr in: Cancer News — ScienceDaily)

- Read more

More clues revealed in link between normal breast changes and invasive breast cancer

15. Okt. 2018

A research team details how a natural and dramatic process — changes in mammary glands to accommodate breastfeeding — uses a molecular process believed to contribute to survival of pre-malignant breast cells. (Mehr in: Cancer News — ScienceDaily)

- Read more

Cells‘ route in response to disease is not always straight

15. Okt. 2018

The steps cells take in response to challenges are more complex than previously thought, finds new research. The study investigates a system relevant to cancer, viral infection, and diabetes. (Mehr in: Cancer News — ScienceDaily)

- Read more

Cancer stem cells use normal genes in abnormal ways

12. Okt. 2018

An new study shows that CDK1 directly interacts with Sox2 to keep cancer cells ‚stemmy.‘ (Mehr in: Cancer News — ScienceDaily)

- Read more

New model mimics human tumors for accurate testing of cancer drugs

11. Okt. 2018

Researchers have genetically engineered a new laboratory model that enables accurate testing of anti-cancer drugs by mimicking the complexity of human cancers. Using this advanced model, researchers will be able to discover the safest and most effective ways to use promising drugs called MCL-1 inhibitors in the clinic. (Mehr in: Cancer News — ScienceDaily)

- Read more

Redrawing the structure of an immune system protein

10. Okt. 2018

Researchers have revealed the structure of an essential immune protein, creating future possibilities to develop more effective medicines for a range of illnesses from cancer to neurological diseases. Researchers made this discovery with computerized image analysis and modern electron microscope imaging. (Mehr in: Cancer News — ScienceDaily)

- Read more

Path to deadly sepsis varies by bacterial infection

10. Okt. 2018

Sepsis remains a common and deadly condition that occurs when the body reacts to an infection in the bloodstream. However, scientists know little about the early stages of the condition. Now, researchers have discovered that host responses during sepsis progression can vary in important ways based on pathogen type — which could lead to more effective treatments. (Mehr in: Cancer News — ScienceDaily)

- Read more

Veranstaltungen

13. ITG Fachtagung Sprachkommunikation

09. Okt. 2018

Die Tagung der Informationstechnischen Gesellschaft (ITG), einer Fachgesellschaft des Verbands der Elektrotechnik, Elektronik, Informationstechnik (VDE), ist eins der größten Treffen von Wissenschaftlern und Praktikern auf dem Gebiet der Sprachverarbeitung im deutschsprachigen Raum. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

62. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e.V.

01. Okt. 2018

Bereits zum zweiundsechzigsten Mal findet 2018 der Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e.V. statt. Vom 31. Oktober bis 3. November diskutieren über 5.000 Expertinnen und Experten im Berliner CityCube den aktuellen Stand der Wissenschaft und Forschung sowie die Zukunft des Fachgebiets der Frauenheilkunde und Geburtshilfe. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

5th International Conference on Cellular Materials (CellMAT), 24 – 26 October

01. Okt. 2018

The 5th CellMAT conference will cover all aspects of manufacturing, functionalizing, modification, joining, property analysis and modelling of cellular materials. In addition to this, featured side events will focus on specific topics. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

7T and beyond: 12th Erwin L. Hahn Lecture

01. Okt. 2018

Höher, schneller, weiter – die immer größer werdenden Feldstärken der MRTs erlauben einmalige und faszinierend detaillierte Aufnahmen aus dem Innern des menschlichen Körpers. Aber bringt die Ultra-Hochfeld-MRT auch Nachteile mit sich? Welchen Schwierigkeiten sehen sich die Forscher und Mediziner bei solch hohen Magnetfeldstärken ausgesetzt? Mit diesen und anderen Fragen beschäftigt sich die diesjährige Erwin L. Hahn Workshop & Lecture unter dem Thema „7T and Beyond“. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

77. BioCon Valley-Treff: „Förderung von Forschung und KMU – Rückenwind von Land, Bund und EU!“

01. Okt. 2018

Mit Verbundforschung eine Brücke zwischen Wissenschaft und Wirtschaft schlagen.

Wenn aus einer Idee ein Produkt werden soll, können Förderprogramme der Schlüssel zum Erfolg sein. Doch welche Möglichkeiten existieren auf Landes-, Bundes- und europäischer Ebene für die Gesundheitswirtschaft? Wie sind die rechtlichen Grundlagen? Wann und wie bewirbt man sich? (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

6. Kooperationsforum Biopolymere

01. Okt. 2018

Das Kooperationsforum „Biopolymere“ ermöglicht den Kontakt zu Technologieunternehmen, Markenherstellern, KMUs, Startups und Experten aus Industrie und Wissenschaft. Der Fokus liegt auf Trends und Strategien und neuen Technologie- und Produktentwicklungen im Bereich biobasierter Materialien/Werkstoffe, Biokunststoffen und Biopolymeren. Zu dem Forum werden ca. 250 Teilnehmer erwartet. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

6. Ambient Medicine® Forum

01. Okt. 2018

Assistive Technik für selbstbestimmtes Wohnen mit dem Forschungsprojekt IBH Living Lab Active & Assisted Living (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen